Search Results - "HOLLER, E"

Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation by Weber, D, Oefner, P J, Dettmer, K, Hiergeist, A, Koestler, J, Gessner, A, Weber, M, Stämmler, F, Hahn, J, Wolff, D, Herr, W, Holler, E

“…Intestinal dysbiosis has been associated with acute gastrointestinal GvHD and poor outcome following allogeneic stem cell transplantation (ASCT). To assess the…”
Get full text

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice by Ruutu, T, Gratwohl, A, de Witte, T, Afanasyev, B, Apperley, J, Bacigalupo, A, Dazzi, F, Dreger, P, Duarte, R, Finke, J, Garderet, L, Greinix, H, Holler, E, Kröger, N, Lawitschka, A, Mohty, M, Nagler, A, Passweg, J, Ringdén, O, Socié, G, Sierra, J, Sureda, A, Wiktor-Jedrzejczak, W, Madrigal, A, Niederwieser, D

“…GVHD remains the major impediment to broader application of allogeneic haematopoietic SCT. It can be prevented completely, but at the expense of other…”
Get full text

Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors by Loganathan, Sudan N, Tang, Nan, Holler, Albert E, Wang, Nenghui, Wang, Jialiang

“…Inhibitors of the bromodomain and extra-terminal domain (BET) family proteins modulate EWS-FLI1 activities in Ewing sarcoma. However, the efficacy of BET…”
Get full text

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD by Hildebrandt, G C, Fazekas, T, Lawitschka, A, Bertz, H, Greinix, H, Halter, J, Pavletic, S Z, Holler, E, Wolff, D

“…This consensus statement established under the auspices of the German working group on BM and blood stem cell transplantation (DAG-KBT), the German Society of…”
Get full text

Biomarkers in chronic graft-versus-host disease: quo vadis? by Wolff, D., Greinix, H., Lee, S. J., Gooley, T., Paczesny, S., Pavletic, S., Hakim, F., Malard, F., Jagasia, M., Lawitschka, A., Hansen, J. A., Pulanic, D., Holler, E., Dickinson, A., Weissinger, E., Edinger, M., Sarantopoulos, S., Schultz, K. R.

“…Biomarkers are increasingly used for diagnosis and treatment of transplant-related complications including the first biomarker-driven interventional trials of…”
Get full text

Endothelial damage is aggravated in acute GvHD and could predict its development by Mir, E, Palomo, M, Rovira, M, Pereira, A, Escolar, G, Penack, O, Holler, E, Carreras, E, Diaz-Ricart, M

“…The aim of the present study was to explore whether there is enhanced endothelial dysfunction in patients developing acute GvHD (aGvHD) after allogeneic…”
Get full text

Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study by Foell, J, Pfirstinger, B, Rehe, K, Wolff, D, Holler, E, Corbacioglu, S

Get full text

Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT by Karl, F., Liang, C., Böttcher-Loschinski, R., Stoll, A., Flamann, C., Richter, S., Lischer, C., Völkl, S., Jacobs, B., Böttcher, M., Jitschin, R., Bruns, H., Fischer, T., Holler, E., Rösler, W., Dandekar, T., Mackensen, A., Mougiakakos, D.

“…•Reconstituting T cells after allo-SCT display increased levels of oxidized DNA damage.•High levels of oxidative T-cell DNA damage are associated with…”
Get full text

Retrospective genome-oriented analysis reveals low transmission rate of multidrug-resistant Pseudomonas aeruginosa from contaminated toilets at a bone marrow transplant unit by Rath, A., Kieninger, B., Hahn, J., Edinger, M., Holler, E., Kratzer, A., Fritsch, J., Eichner, A., Caplunik-Pratsch, A., Schneider-Brachert, W.

“…Prevention of toilet-to-patient transmission of multidrug-resistant Pseudomonas aeruginosa (MDR PA) poses management-related challenges at many bone marrow…”
Get full text

Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease by Grauer, Oliver, Wolff, Daniel, Bertz, Hartmut, Greinix, Hildegard, Kühl, Jörn-Sven, Lawitschka, Anita, Lee, Stephanie J., Pavletic, Steven Z., Holler, Ernst, Kleiter, Ingo

“…A major obstacle of allogeneic haematopoietic stem cell transplantation is graft-versus-host disease, an immune-mediated disorder that affects multiple tissues…”
Get full text

Identification and validation of biomarkers associated with acute and chronic graft versus host disease by Ahmed, S S, Wang, X N, Norden, J, Pearce, K, El-Gezawy, E, Atarod, S, Hromadnikova, I, Collin, M, Holler, E, Dickinson, A M

“…Graft versus host disease (GVHD) is a major complication of haematopoietic SCT (HSCT). A number of inflammatory cytokines/chemokines are implicated in GVHD and…”
Get full text

Reference point insensitive molecular data analysis by Altenbuchinger, M, Rehberg, T, Zacharias, H U, Stämmler, F, Dettmer, K, Weber, D, Hiergeist, A, Gessner, A, Holler, E, Oefner, P J, Spang, R

“…In biomedicine, every molecular measurement is relative to a reference point, like a fixed aliquot of RNA extracted from a tissue, a defined number of blood…”
Get full text

Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes by Vrhovac, R, Labopin, M, Ciceri, F, Finke, J, Holler, E, Tischer, J, Lioure, B, Gribben, J, Kanz, L, Blaise, D, Dreger, P, Held, G, Arnold, R, Nagler, A, Mohty, M

“…Limited therapeutic options are available after relapse of acute leukaemia following first reduced intensity conditioning haematopoietic stem cell…”
Get full text

Differential Activity of PARP Inhibitors in BRCA1 - Versus BRCA2 -Altered Metastatic Castration-Resistant Prostate Cancer by Taza, Fadi, Holler, Albert E, Fu, Wei, Wang, Hao, Adra, Nabil, Albany, Costantine, Ashkar, Ryan, Cheng, Heather H, Sokolova, Alexandra O, Agarwal, Neeraj, Kessel, Adam, Bryce, Alan, Nafissi, Nellie, Barata, Pedro, Sartor, A Oliver, Bastos, Diogo, Smaletz, Oren, Berchuck, Jacob E, Taplin, Mary-Ellen, Aggarwal, Rahul, Sternberg, Cora N, Vlachostergios, Panagiotis J, Alva, Ajjai S, Su, Christopher, Marshall, Catherine H, Antonarakis, Emmanuel S

“…Two poly (ADP-ribose) polymerase (PARP) inhibitors (olaparib and rucaparib) are US Food and Drug Administration-approved for patients with metastatic…”
Get more information

Polymorphisms of cytokine and innate immunity genes and GVHD by Dickinson, A.M, Holler, E

“…In the last 10 years, non-HLA genotypes have been investigated for their potential roles in the occurrence and severity of graft-versus-host disease (GVHD) as…”
Get full text

Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation by Weissinger, E M, Metzger, J, Dobbelstein, C, Wolff, D, Schleuning, M, Kuzmina, Z, Greinix, H, Dickinson, A M, Mullen, W, Kreipe, H, Hamwi, I, Morgan, M, Krons, A, Tchebotarenko, I, Ihlenburg-Schwarz, D, Dammann, E, Collin, M, Ehrlich, S, Diedrich, H, Stadler, M, Eder, M, Holler, E, Mischak, H, Krauter, J, Ganser, A

“…Allogeneic hematopoietic stem cell transplantation is one curative treatment for hematological malignancies, but is compromised by life-threatening…”
Get full text

Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: Results of treatment with the COBE Spectra System by Hautmann, A H, Wolff, D, Hahn, J, Edinger, M, Schirmer, N, Ammer, J, Holler, B, Landfried, K, Hautmann, M G, Ahrens, N, Ugocsai, P, Andreesen, R, Holler, E

“…In this retrospective analysis, 30 patients with acute GVHD (aGVHD) and 32 patients with chronic GVHD (cGVHD) treated with extracorporeal photopheresis (ECP)…”
Get full text

The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation by Weissinger, E M, Human, C, Metzger, J, Hambach, L, Wolf, D, Greinix, H T, Dickinson, A M, Mullen, W, Jonigk, D, Kuzmina, Z, Kreipe, H, Schweier, P, Böhm, O, Türüchanow, I, Ihlenburg-Schwarz, D, Raad, J, Durban, A, Schiemann, M, Könecke, C, Diedrich, H, Holler, E, Beutel, G, Krauter, J, Ganser, A, Stadler, M

“…Allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be curative, but is associated with significant morbidity and mortality. Chronic…”
Get full text

Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset by Bohmann, E.-M., Fehn, U., Holler, B., Weber, D., Holler, E., Herr, W., Hoffmann, P., Edinger, M., Wolff, D.

“…We analyzed lymphocyte subpopulations and cytokines 3 months after allogeneic hematopoietic stem cell transplantation aiming to identify predictive cellular…”
Get full text

Assessing COVID-19 Health Information on Google Using the Quality Evaluation Scoring Tool (QUEST): Cross-sectional and Readability Analysis by Bachu, Vismaya S, Mahjoub, Heba, Holler, Albert E, Crihalmeanu, Tudor, Bachu, Dheevena M, Ayyaswami, Varun, Parker, Pearman D, Prabhu, Arpan V

“…The COVID-19 pandemic spurred an increase in online information regarding disease spread and symptomatology. Our purpose is to systematically assess the…”
Get full text